Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan
· Delayed Price · Currency is TWD 24.70
+0.35 (1.44%)
At close: Mar 6, 2026
Orient Pharma Market Cap
Orient Pharma has a market cap or net worth of 6.00 billion as of March 6, 2026. Its market cap has decreased by -28.42% in one year.
Market Cap
6.00B
Enterprise Value
5.66B
Revenue
1.28B
Ranking
n/a
PE Ratio
43.50
Stock Price
24.70
Market Cap Chart
Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 6.00B, an increase of 45.84%. That is a compound annual growth rate of 2.79%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 5.96B |
| Formosa Laboratories | 6.31B |
| Orient EuroPharma | 3.80B |
| Easywell Biomedicals | 3.52B |
| LIWANLI Innovation | 3.35B |
| Merdury Biopharmaceutical | 3.32B |
| Alar Pharmaceuticals | 11.16B |
| Standard Chemical & Pharmaceutical | 11.44B |